20 January 2019

My name is Febrina Meutiawati and I am Indonesian. I’m currently pursuing my PhD in Medical Microbiology Department, at the Experimental Virology Group, Theme Infectious diseases and global health.

When you were a kid what did you want to be when you grew up? Can you tell us something about your child years. 

Since my mother is a teacher in physics, being a teacher was one of my dreams. Besides that, I remembered that I was more interested in life science subjects rather than social and literature subjects. However, as a kid, I was clueless on what scientists do. I only knew one scientist (sadly, a fictional character), dr. Dana Scully. Thanks to the TV series, I gained my interest to the scientific world.

What was your previous academic training, where did you study and why that study? 

I got my Bachelor and Master degree on Chemistry and Biochemistry from Bandung Institute of Technology. I was impressed by the scope of chemistry subject which is basically related to everything; physics, biology, medicine and even sometimes philosophy. Therefore, I chose to study the subject. Over time, my interest was more focus on molecular biology and was broaden to virology because there I can understand the molecular mechanism of disease in general, and viruses in specific. Moreover, cell culture works and plaque assays are quite exciting!

The RIMLS motto is: ‘Today’s molecules for tomorrow’s medicine’. What does this mean for you? 

The motto basically represents the general topic of my PhD projects of which focus on discovery of antiviral drugs for mosquito-borne viruses. Our approach is by repurposing the collection of small drug-like compounds for antiviral activity screening to identify ones that inhibit dengue virus. Therefore, for me personally, this means every data matters, no experiment goes in vain. Our today’s pointless results may become very useful someday.

Who is your great example as scientists? And please give a motivation why.

I actually use everyone as great examples, and as scientists, I learned a lot from my supervisors and colleagues. However, I am greatly motivated by Dr. Angelle Desiree LaBeaud because she’s one of the myth-breakers of motherhood in science. This year, she received a Woman in Science Award  given by International Society of Antiviral Research for her contribution in investigating the epidemiology of arboviral infection, in particular her dedication in arbovirus research in Kenya. From her experience, I can learn that there is a possibility to have an elevating career in science without having to choose between family and work. 

Which research discovery that you have made has made you most proud? 

I’m currently working on the discovery of novel antiviral drugs for dengue virus, one of the most pathogenic mosquito-borne virus. One discovery that I contributed to (of which i’m very proud of) is identification of the target from one of our antiviral drug candidates, posaconazole. Moreover, the host target that we identified was never been reported to be involved in dengue virus replication mechanism before. Therefore, besides identified the target of posaconazole for its inhibition activity against dengue virus, we also found a potential host target that can be a candidate for further antiviral drug development. 

Given unlimited finance what experiment would you perform?

Of course, clinical trials of the dengue antiviral drug candidates that have been successfully characterized. Besides that, I’d like to build a research center focusing on antiviral drug screening and characterization on natural sources in Indonesia.

What does your working area (desk, office) look like and what does it say about you (or your research)? 

It’s intermediate, I’d say. Not so tidy yet not so messy. I’m not entirely sure what it says about my research, though. However, if you happen to see my desk super clean, that means I’m either on holiday or  in a serious stress.

Nominate a colleague to be in the spotlight and what would you like to ask him or her?

Bodine Bezemer. If you only have two options to survive in this world: listening to the whole album of Kensington every single day or make 100 types of replicon ….. stable cell lines, which one will you choose?

What type of person are you, quick insights:

a) Mac or PC?                                : Mac
b) Theater or cinema?                 : Cinema
c) Dine out or dine in?                 : Dine in
d) Ferrari or Fiat?                         : Neither
e) Shopaholic or chocoholic?     : Shop-a-choco-holic
f) Culture or Nature                     : Nature

Related news items


Jong KNCV organizes a Pitch competition for PhD candidates

13 August 2020

Are you a PhD candidate and would you like to win 500 euros with a pitch about your research? Young KNCV gives you that chance! During the KNCV Chemistry 2020 Evening on October 8th.

read more

Collective invasion induced by autocrine purinergic loop through connexin-43 hemichannels

13 August 2020

Peter Friedl and Paul Span show in Journal of Cell Biology that breastcancer cells release purines into the extracellular space via connexin-43 hemichannels to control collective invasion.

read more

TP53 allelic state is critical for diagnostic and prognostic precision in blood cancer

12 August 2020

An international study, in which Joop Jansen participated, shows that a double mutaton in TP53 gene deteriotes the prognosis of a rare form of blood cancer. If there is only one mutation or no mutation, then the prognosis is better.

read more

BCG vaccine is safe with no increased risk of COVID-19 symptoms says Mihai Netea

11 August 2020

The BCG vaccine has a general stimulatory effect on the immune system and is therefore effective against multiple infectious diseases - possibly also against COVID-19.

read more

ERC Proof of Concept grant received by Ronald van Rij

30 July 2020

Ronald van Rij, theme Infectious diseases and global health, received an ERC (European Research Council) Proof of Concept grant of 150,000 euros, in order to make arbovirus vaccines even safer.

read more

Hypatia fellowship Call is open

30 July 2020

The Hypatia fellowship round with the deadline 31 May has been canceled. Therefore, the next available deadline will be 27 September 2020. Radboudumc researchers are invited to scout young potentials to fill the strategic gaps within the research themes imbedded in RIHS and RIMLS.  

read more